News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-29 9:27:9 am Verrica Pharmaceuticals Inc. (VRCA) Q4 2023 Earnings Call Transcript SeekingAlpha
2024-02-29 5:11:14 am Verrica Pharmaceuticals Inc (VRCA) Reports Fourth Quarter and Full-Year 2023 Financial Results GuruFocus.com
2024-02-29 4:30:0 am Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results GlobeNewswire
2024-02-27 4:30:0 am Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference GlobeNewswire
2024-02-22 4:30:0 am Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024 GlobeNewswire
2024-02-05 4:30:0 am Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition GlobeNewswire
2024-01-29 4:30:0 am Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services GlobeNewswire
2024-01-22 4:44:13 pm 7 Potential Short-Squeeze Stocks Poised for Rapid Gains InvestorPlace
2024-01-05 4:30:0 am Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information